Showing results (91-100 of 329) with videos related to
Sort By:
Pageof 33
Postgraduate Medicine|March 23, 2017
A practical guide to the sublingual immunotherapy tablet adverse event profile: implications for clinical practiceDavid I Bernstein, Jose A Bardelas, Bodil Svanholm Fogh, et al.Antimicrobial Agents and Chemotherapy|November 17, 2010
Oral hexadecyloxypropyl-cidofovir therapy in pregnant guinea pigs improves outcome in the congenital model of cytomegalovirus infectionFernando J Bravo, David I Bernstein, James R Beadle, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 2005
Evaluation of imiquimod 5% cream to modify the natural history of herpes labialis: a pilot studyDavid I Bernstein, Spotswood L Spruance, Sujata S Arora, et al.Human Vaccines & Immunotherapeutics|January 12, 2019
Evidence for cross-protection but not type-replacement over the 11 years after human papillomavirus vaccine introductionCourtney Covert, Lili Ding, Darron Brown, et al.Human Immunology|July 24, 2010
Age-related changes in magnitude and diversity of cross-reactive CD4+ T-cell responses to the novel pandemic H1N1 influenza hemagglutininRamu A Subbramanian, Saleem Basha, Rebecca C Brady, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 12, 2009
Epidemiology and risk factors for human papillomavirus infection in a diverse sample of low-income young womenTasneem Shikary, David I Bernstein, Yan Jin, et al.Antiviral Research|October 20, 2023
Intermittent therapy with helicase-primase inhibitor IM-250 efficiently controls recurrent herpes disease and reduces reactivation of latent HSVDavid I Bernstein, Nancy M Sawtell, Fernando J Bravo, et al.The Journal of Allergy and Clinical Immunology. in Practice|June 29, 2016
Coseasonal Initiation of Allergen Immunotherapy: A Systematic ReviewPeter S Creticos, David I Bernstein, Thomas B Casale, et al.Viruses|November 11, 2022
Immunisation Using Novel DNA Vaccine Encoding Virus Membrane Fusion Complex and Chemokine Genes Shows High Protection from HSV-2Ursula A Gompels, Fernando J Bravo, Sean Briggs, et al.The Journal of Infectious Diseases|April 10, 2004
Protection against congenital cytomegalovirus infection and disease in guinea pigs, conferred by a purified recombinant glycoprotein B vaccineMark R Schleiss, Nigel Bourne, Greg Stroup, et al.Pageof 33